Search

everythinglearnresearchcommunity

for

Search:↓

Protein kinase C epsilon may promote skin cancer development after UV exposure by affecting nearby cells.

Protein kinase C epsilon may increase skin cancer risk by affecting nearby cells.

Overexpressing PKCepsilon in mice reduces papillomas but increases carcinomas.

Entospletinib effectively prevents eye and skin GVHD in mice.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

A two-step method was created in 2015 to make more cells that help with hair growth, but they need to be combined with other cells for 4 days to actually form new hair.

Tadalafil and Finasteride may help treat aggressive melanoma.

TAK-279 effectively reduces psoriasis symptoms and is safe.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Rapamycin treatment helps with mitochondrial disease by reducing PKC levels.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

The combination treatment showed a higher response rate but no significant survival benefits.

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.

Blocking YAP/TAZ could be a new way to treat skin cancer.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Promising cancer treatments were found, but the manufacturer closed.

Protein Kinase Cε increases skin sensitivity to UV damage and skin cancer risk.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.